These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28008255)

  • 1. Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator-and apolipoprotein E-conjugated liposomes to the hippocampus.
    Kuo YC; Lee YJ
    Int J Nanomedicine; 2016; 11():6809-6824. PubMed ID: 28008255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration.
    Kuo YC; Chen CL; Rajesh R
    Acta Biomater; 2019 Mar; 87():207-222. PubMed ID: 30716553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer's disease treatment.
    Kuo YC; Lin CY; Li JS; Lou YI
    Int J Nanomedicine; 2017; 12():1757-1774. PubMed ID: 28280340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide.
    Kuo YC; Lin CY
    J Drug Target; 2015 Feb; 23(2):147-58. PubMed ID: 25268274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin.
    Kuo YC; Wang CT
    Biomaterials; 2014 Jul; 35(22):5954-64. PubMed ID: 24746790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin.
    Kuo YC; Tsao CW
    Int J Nanomedicine; 2017; 12():2857-2869. PubMed ID: 28435263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin.
    Kuo YC; Chou PR
    J Pharm Sci; 2014 Aug; 103(8):2484-97. PubMed ID: 25041794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione- and apolipoprotein E-grafted liposomes to regulate mitogen-activated protein kinases and rescue neurons in Alzheimer's disease.
    Kuo YC; Ng IW; Rajesh R
    Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112233. PubMed ID: 34225874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
    Rodrigues BDS; Kanekiyo T; Singh J
    Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual functional liposomes carrying antioxidants against tau hyperphosphorylation and apoptosis of neurons.
    Kuo YC; Lou YI; Rajesh R
    J Drug Target; 2020 Nov; 28(9):949-960. PubMed ID: 32338078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.
    Bana L; Minniti S; Salvati E; Sesana S; Zambelli V; Cagnotto A; Orlando A; Cazzaniga E; Zwart R; Scheper W; Masserini M; Re F
    Nanomedicine; 2014 Oct; 10(7):1583-90. PubMed ID: 24333591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
    Kuo YC; Rajesh R
    Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin.
    Kuo YC; Lin CC
    Int J Nanomedicine; 2015; 10():2653-72. PubMed ID: 25878499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons.
    Beffert U; Aumont N; Dea D; Lussier-Cacan S; Davignon J; Poirier J
    J Neurochem; 1998 Apr; 70(4):1458-66. PubMed ID: 9523562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
    Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
    Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
    Kong L; Li XT; Ni YN; Xiao HH; Yao YJ; Wang YY; Ju RJ; Li HY; Liu JJ; Fu M; Wu YT; Yang JX; Cheng L
    Int J Nanomedicine; 2020; 15():2841-2858. PubMed ID: 32425521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.
    Mellott TJ; Pender SM; Burke RM; Langley EA; Blusztajn JK
    PLoS One; 2014; 9(4):e94287. PubMed ID: 24732467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BV2 Membrane-Coated PEGylated-Liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy.
    Wang HC; Yang W; Xu L; Han YH; Lin Y; Lu CT; Kim K; Zhao YZ; Yu XC
    Adv Healthc Mater; 2024 Jul; 13(19):e2400125. PubMed ID: 38513154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer's Disease Mice.
    Fonar G; Polis B; Sams DS; Levi A; Malka A; Bal N; Maltsev A; Elliott E; Samson AO
    Mol Neurobiol; 2021 May; 58(5):2322-2341. PubMed ID: 33417228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.